Influenza

This medication is the first FDA-approved OTC innovation in the cold and flu category in 14 years.

Coadministering COVID-19 and influenza vaccines did not raise the 90-day risk of serious or clinically meaningful adverse events.

FDA advisors back Moderna’s mRNA flu shot for older adults, hinting at a potential egg-free option for 2026–2027.

FDA clears first generic Xofluza tablet, bringing affordable single-dose flu treatment and prevention.

In a reversal of its refusal-to-file letter issued last week, the FDA decides to move forward with Moderna’s mRNA flu vaccine developments.

A pharmacist's guidance is essential when selecting effective OTC cold and influenza medications that provide relief from symptoms such as cough, congestion, and fever.

Due to an increased risk of vaccine-preventable diseases, researchers explore pneumococcal, COVID-19, and influenza vaccine coverage among people living with HIV in Belgium.

Among older adults with Medicare, researchers investigated national influenza vaccination patterns by race, education level, and rurality.

Simultaneous vaccination with IIV4 and PPSV23 proves safe and effective for patients with chronic diseases, matching results of healthy individuals.

Novavax’s H5N1 avian influenza vaccine candidate shows a robust immune response with 1- and 2-dose intranasal or intramuscular administration for nonhuman primates.

Secretary of US Health and Human Services Robert F. Kennedy Jr also approved all recommendations issued from the April ACIP meeting.

Flu vaccination significantly reduces illness in vaccinated and unvaccinated individuals, highlighting its importance in public health strategies.

Researchers determined the impact COVID-19 interventions had on Danish children’s incidence of RSV, influenza, and invasive pneumococcal disease.

ACIP also discusses COVID-19 epidemiology as well as safety and efficacy for the COVID-19 vaccines.

CD388 is being investigated as a prevention method for seasonal influenza in unvaccinated patients aged 18 to 64 years.

Researchers wanted to address the potential impact of pharmacist-led influenza immunization services on vaccine uptake in older adults living in Denmark.

Currently under development, the manufacturer’s investigational pandemic influenza vaccine is designed to target the H5 avian influenza virus, or bird flu.

The investigators hope to pursue a human vaccine in order to improve upon the already existing vaccines.

Patients with psychosis, depression, and anxiety exhibit higher rates of vaccine hesitancy.

Global virus and public health experts gathered to assess the need for an enhanced response to the bird flu spreading among humans and animals.

Investigators specifically analyze information on influenza and pneumococcal vaccinations.

The designation addresses the unmet need for prevention of H5N1, which remains a global health risk, and a phase 1 trial of the vaccine was initiated in November 2024.

Coalition for Epidemic Preparedness Innovations experts warned of the potential for bird flu to become a pandemic event if officials don’t prepare quickly.

Researchers investigated the acceptability of community pharmacy-led influenza vaccination and patients’ willingness to return for future immunization.

With the disease burden remaining high, CVS Health announces new flu testing and treatment capabilities at approximately 1600 locations in selected states.